Pierre Hubert Andre Chauvineau

Sequana Medical AG operates as a medical device company. It specializes in the production and design of implantable pump systems to manage fluid balance within the body. The firm offers the Alfapump system, its proprietary solution to manage and remove ascites, which can occur as a symptom of liver disease, cancer, or congestive heart failure and its focus areas encompass clinical research, product innovation, and technology development. The company was founded by Noel L. Johnson in 2000 and is headquartered in Zurich, Switzerland.

JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE.

PX Therapeutics SA manufactures and develops recombinant proteins and monoclonal antibodies. Its services include protein engineering, optimization of drug candidates, humanization of antibodies, and production and release of GMP batches for clinical studies. The firm specializes in the field of in-vivo and in-vitro diagnostics, industrial enzymes, and ancillary products. The company was founded by Tristan Rousselle and Nicolas Mouz in November 2000 and is headquartered in Grenoble, France.

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

GC Aesthetics Plc designs, manufactures and distribute implantable medical devices. The firm operates through two brands: Nagor and Eurosilicone. Its global aesthetics products market includes the following segments: breast implant products, skin tightening and body shaping, energy devices, neuro modulators, dermal fillers, chemical peels, liposuctions, self and physician dispensed topical and injectables, removal of localized fat deposits, device-based alternatives to toxins for wrinkle reduction and therapy treatments for hair loss, excessive sweating (hyperhidrosis), malfunctioning veins (sclerotherapy) and scars. The company was founded by William McCabe in April 2015 and is headquartered in Dublin, Ireland.

Global Consolidated Aesthetics Ltd. develops, manufactures and sells breast implants. It offers products under flagship brands Nagor and Eurosilicone. The firm manufactures products at its own facilities based in Scotland, England and France and produces to the highest European standards. The company was founded in 2007 and is headquartered in Dublin, Ireland.

Jefferies International Ltd. (JIL) is a brokerage firm headquartered in London, UK. The firm was founded in 1986 and is a subsidiary of Jefferies Holdings II Ltd., ultimately held by Jefferies Financial Group, Inc. (NYSE: JEF) in the US. JIL provides broking services to various investors.

Part of Deutsche Bank AG, Deutsche Bank SA/NV is a commercial bank based in Brussels, Belgium.

ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK.

Part of Abbott Laboratories, Abbott Laboratories Ltd. is a British company that manufactures, develops and sells pharmaceutical and nutritional products. The company is based in Maidenhead, UK and was founded in 1937.

Locate Bio Ltd. operates as a regenerative medicine development company. The firm focuses on clinical problems in which regeneration of human tissue will displace biomaterial or drug therapies. Its products are orthopaedic matrices with unique properties for hard to heal clinical applications. The company was founded by Robin Quirk and is headquartered in Nottingham, the United Kingdom.

Part of MicroPort Scientific Corp., Lombard Medical Ltd. is a provider and champion of innovative solutions for the treatment of vascular disease. The company is based in Didcot, UK and was founded in 1994 by Peter William Phillips. The British company offers a range of products for the treatment of aortic disease, including Minos™ - EVAR, Aorfix™ - EVAR, Altura™ - EVAR, Meridian™ - FEVAR, Hercules™ - TEVAR, Castor™ - TEVAR, and Hercules Balloon Catheter™. Lombard Medical is passionately committed to serving clinicians and patients and consistently achieves exceptional results in everything they do.

Altura Medical, Inc. manufactures medical devices. It offers Agili-D AAA System, an endovascular aneurysm repair technology. The company was founded in 2008 and is headquartered in Irvine, CA.

Pertinax Pharma Ltd. manufactures pharmaceutical products. developing medical, healthcare and veterinary applications of a novel, proprietary long acting formulation of the already widely used antimicrobial drug chlorhexidine. Pertinax Pharma was founded by Michele Barbour in 2015 and is headquartered in Bristol, the United Kingdom.

Elicityl SA offers complex sugar research, development and manufacturing services. It The firmengages in the research and production of oligosaccharides (complex sugar) for agriculture, pharmacy, nutraceutic, and cosmetic uses. The firm's services encompass sampling line capabilities to industrial process designed top increase production. The company was registered in May 28, 2002 and is headquartered in Crolles, France.

GENOME express SA develops and markets value-added solutions for functional genomics. The company provides a platform that integrates proprietary tools for genomics, transcriptomics and proteomics. GENOME express offers services for international biotechnology, agric-food, veterinary and pharmaceutical companies and for academic laboratories to accelerate their global discovery process. The company was founded in 1994 and is headquartered in Meylan, France.

Part of Ferghana Partners Group, Gargoyle Partners is a British company that provides healthcare and chemicals mergers and acquisition advisory. The company is based in London, UK. Gargoyle Partners was acquired by Ferghana Partners Group on October 11, 2005.

Bio-Incubator Leuven is a dynamic and innovative environment that provides lab space and support to R&D-intensive life sciences companies. The private company offers customizable modules that can be modified to meet the specific requirements of each client. The company is based in Leuven, Belgium. Leuven's knowledge institutes, including KU Leuven, University Hospitals Leuven, VIB, and IMEC, generate a huge outflow of knowledge that entails a myriad of innovative ideas for new and existing companies. The CEO of the Belgian company is Michaël de Blauwe.

Part of The European Molecular Biology Laboratory, EMBL Enterprise Management Technology Transfer GmbH is an alternative investment manager. The company is based in Heidelberg, Germany. The German company was founded in 1999. The CEO is Gabor M. Lamm.

FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen.

Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium.

reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium.

LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies.

Curetis GmbH operates as a molecular diagnostics company which focuses on the development and commercialization of products for diagnosing severe infectious diseases. The firm offers diagnostic solutions for hospitals and large-scale laboratories. Its products include Unyvero L4 Lysator, Unyvero C8 Cockpit, Unyvero A50 Analyzer, and Unyvero Application Cartridges. The company was founded by Andreas Boos, Johannes Bacher, Gerd Lüdke, and Anne Thews in August 2007 and is headquartered in Holzgerlingen, Germany.

Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium.

Lumeon Ltd. operates as a digital health company. It offers cloud-based management platform for outpatient care providers including doctors, ophthalmologists, and physiotherapists. The firm?s platform offers pre-operative and discharge readiness, chronic disease, post-acute care, lifestyle coaching, and imaging optimization solutions. The company was founded by Robbie M. Hughes on August 4, 2005 and is headquartered in London, the United Kingdom.

Stichting De Weijerhorst provides welfare and pension funds. The company is headquartered in Maastricht, the Netherlands.